Jaguar Health Inc [JAGX] stock is trading at $0.81, down -5.37%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The JAGX shares have gain 17.09% over the last week, with a monthly amount drifted -28.40%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Jaguar Health Inc [NASDAQ: JAGX] stock has seen the most recent analyst activity on July 07, 2021, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $5. Previously, Rodman & Renshaw started tracking the stock with Buy rating on July 11, 2017, and set its price target to $2.
Jaguar Health Inc [JAGX] stock has fluctuated between $0.64 and $25.75 over the past year. Currently, Wall Street analysts expect the stock to reach $12.98 within the next 12 months. Jaguar Health Inc [NASDAQ: JAGX] shares were valued at $0.81 at the most recent close of the market. An investor can expect a potential return of 1502.47% based on the average JAGX price forecast.
Analyzing the JAGX fundamentals
Jaguar Health Inc [NASDAQ:JAGX] reported sales of 11.79M for the trailing twelve months, which represents a drop of -0.80%. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at -2.79%, Pretax Profit Margin comes in at -3.48%, and Net Profit Margin reading is -3.42%. To continue investigating profitability, this company’s Return on Assets is posted at -0.81, Equity is -7.11 and Total Capital is -2.46. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of5.67.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Jaguar Health Inc’s Current Ratio is 0.81. Also, the Quick Ratio is 0.52, while the Cash Ratio stands at 0.1. Considering the valuation of this stock, the price to sales ratio is 0.26, the price to book ratio is 0.95.
